The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Cocaine Dependence and D2 Receptor Availability in the Functional Subdivisions of the Striatum: Relationship with Cocaine-Seeking Behavior
Abstract
Striatal dopamine D2 receptors have been implicated in the neurobiology of cocaine addiction. Previous imaging studies showed reduced striatal D2 receptor availability in chronic cocaine abusers, and animal studies suggested that low D2 receptor availability promotes cocaine self-administration. Here, D2 receptor availability was assessed with positron emission tomography (PET) and [11C]raclopride in the limbic, associative, and sensori-motor subdivisions of the striatum in 17 recently detoxified chronic cocaine-dependent (CCD) subjects and 17 matched healthy control (HC) subjects. In addition, the relationship between regional D2 receptor availability and behavioral measures obtained in cocaine self-administration sessions was investigated in CCD subjects. [11C]Raclopride binding potential was significantly reduced by 15.2% in the limbic striatum, 15.0% in the associative striatum, and 17.1% in the sensori-motor striatum in CCD subjects compared to HC subjects. In CCD subjects, no relationship was detected between D2 availability in striatal regions and either the positive effects of smoked cocaine or the choice of cocaine over an alternative reinforcer (money) following a priming dose of cocaine (a laboratory model of relapse). Thus, this study confirms previous reports of a modest decrease in D2 receptor availability in CCD subjects, and establishes that this decrease is generalized throughout the striatum. However, this study failed to demonstrate a relationship between D2 receptor availability and cocaine-induced cocaine-taking behavior. Additional research is warranted to unravel potential neurobiological traits that might confer vulnerability to relapse in detoxified CCD subjects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are multiple lines of evidence that cocaine dependence is associated with a decrease in D2 receptor binding [164-167], a pattern that seems to persist after disease remission [165].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [164]
In the citing paper
“The first report was in 1990, where a study showed that cocaine abuse was associated with a decrease in D2 receptor availability in the striatum compared to controls (Volkow et al, 1990), and has been followed by a series of studies confirming this observation”
From Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity (2014) · cites this paper as Martinez et al., 2004
Citations
Cites
A theory for multiresolution signal decomposition: the wavelet representation
Mallat, S. (1989) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/34.192463 · Cited by 21,463
Statistical parametric maps in functional imaging: A general linear approach
Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Sokoloff, P., Bruno Giros, A., Martres, M., Bouthenet, M.-L., & Schwartz, J. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,608
Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
Rapid Automated Algorithm for Aligning and Reslicing PET Images
Woods, R. P., Cherry, S. R., & Mazziotta, J. C. (1992) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199207000-00024 · Cited by 1,901
Wang, G.-J., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusll, N., & Fowler, J. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03643-6 · Cited by 1,864
MRI-PET Registration with Automated Algorithm
Woods, R. P., Mazziotta, J. C., & Cherry, A. S. R. (1993) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199307000-00004 · Cited by 1,636
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020
Self-citationVolkow, N. D., Fowler, J. S., Wang, G., Hitzemann, R., Logan, J., Schlyer, D. J., Dewey, S. L., & Wolf, A. P. (1993) · Synapse · doi:10.1002/syn.890140210 · Cited by 924
Flagged first, then by citations
Research works printed but not linked: 4
- Beck A, Steer R, Brown G (1996). BDIII Beck Depression Inventory Manual, 2nd ed. Harcourt Brace & Company: San Antonio, TX.
- First M, Spitzer R, Gibbon M, Williams J (1995). Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I/P, Version 2.0). Biometrics Research Dept., New York State Psychiatric Institute: New York.
- First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin L (1994). Structured Clinical Interview for DSM-IV Axis II personality disorders (SCID-II, Version 2.0). Biometrics Research Department, New York State Psychiatric Department: New York.
- Lemarie PG (1988). Ondelettes with exponential localization. J Math Pure Appl 67: 227–236.
Cited by
Sorted by citations
Items 101–200 of 306
Proebstl, L., Kamp, F., Manz, K., Krause, D., Adorjan, K., Pogarell, O., Koller, G., Soyka, M., Falkai, P., & Kambeitz, J. (2019) · European psychiatry · doi:10.1016/j.eurpsy.2019.03.003 · Cited by 52
Nonhuman primate models of social behavior and cocaine abuse
Nader, M. A., Czoty, P. W., Nader, S. H., & Morgan, D. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2843-5 · Cited by 52
Haile, C. N., Mahoney, J. J., Newton, T. F., & Garza, R. D. L. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.010 · Cited by 56
Marcellino, D. J., Roberts, D. C. S., Navarro, G., Filip, M., Agnati, L. F., Lluı́s, C., Franco, R., & Fuxé, K. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.079 · Cited by 52
Imaging Neurotransmitter Release by Drugs of Abuse
Martínez, D., & Narendran, R. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_34 · Cited by 50
Belujon, P., Jakobowski, N. L., Dollish, H. K., & Grace, A. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.191 · Cited by 52
Imaging the Neurochemistry of Alcohol and Substance Abuse
Martínez, D., Kim, J., Krystal, J. H., & Abi‐Dargham, A. (2007) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2007.07.004 · Cited by 50
Stefański, R., Ziółkowska, B., Kuśmider, M., Mierzejewski, P., Wyszogrodzka, E., Kołomańska, P., Dziedzicka‐Wasylewska, M., Przewłocki, R., & Kostowski, W. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.074 · Cited by 49
Smith, C. T., Dang, L. C., Buckholtz, J. W., Tetreault, A. M., Cowan, R. L., KESSLER, R. M., & Zald, D. H. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.45 · Cited by 45
Potvin, S., Blanchet, P. J., & Stip, É. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.06.010 · Cited by 46
Associating resting-state connectivity with trait impulsivity
Angelides, N. H., Gupta, J., & Vickery, T. J. (2017) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsx031 · Cited by 48
Preller, K. H., Ingold, N., Hulka, L. M., Vonmoos, M., Jenni, D., Baumgartner, M. R., Vollenweider, F. X., & Quednow, B. B. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.08.003 · Cited by 47
Nader, M. A., & Banks, M. L. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.044 · Cited by 45
Gozzi, A., Tessari, M., Dacome, L., Agosta, F., Lepore, S., Lanzoni, A., Cristofori, P. G., Pich, E. M., Corsi, M., & Bifone, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.129 · Cited by 49
Robinson, S., Eslambolchilar, P., & Jones, M. (2009) · International Conference on Human-Computer Interaction with Mobile Devices and Services (MobileHCI) · doi:10.1145/1613858.1613874 · Cited by 46
Worhunsky, P. D., Matuskey, D., Gallezot, J., Gaiser, E., Nabulsi, N., Angarita, G. A., Calhoun, V. D., Malison, R. T., Potenza, M. N., & Carson, R. E. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.01.045 · Cited by 44
Recovering from cocaine: Insights from clinical and preclinical investigations
Hanlon, C. A., Beveridge, T. J. R., & Porrino, L. J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.007 · Cited by 45
Imaging Receptor Changes in Human Drug Abusers
Cosgrove, K. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_24 · Cited by 41
Gould, R. W., Duke, A. N., & Nader, M. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.004 · Cited by 39
Brown, A. L., Flynn, J. R., Smith, D. W., & Dayas, C. V. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001367 · Cited by 42
Can the reinforcing value of food be measured in bulimia nervosa?
Schebendach, J., Broft, A. I., Foltin, R. W., & Walsh, B. T. (2012) · Appetite · doi:10.1016/j.appet.2012.11.009 · Cited by 40
Self-citationDrugs currently in Phase II clinical trials for cocaine addiction
Kim, J. H., & Lawrence, A. J. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.915312 · Cited by 40
Slifstein, M., Hwang, D., Martinez, D., Ekelund, J., Huang, Y. H., Hackett, E., Abi‐Dargham, A., & Laruelle, M. A. (2006) · PubMed · Cited by 39
Self-citationBoileau, I., Nakajima, S., & Payer, D. E. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.002 · Cited by 35
Urban, N., & Martínez, D. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.03.011 · Cited by 35
Kawamichi, H., Sugawara, S. K., Hamano, Y. H., Makita, K., Matsunaga, M., Tanabe, H. C., Ogino, Y., Saito, S., & Sadato, N. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.01763 · Cited by 41
Therapeutic doses of buspirone block D3 receptors in the living primate brain
Kim, S. W., Fowler, J. S., Skolnick, P., Muench, L., Kang, Y., Shea, C. E., Logan, J., Kim, D., Carter, P., King, P. T., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000194 · Cited by 32
Dopamine Receptor Subtypes in Reward and Relapse
Self, D. W. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-333-6_17 · Cited by 35
Trifilieff, P., & Martínez, D. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00044 · Cited by 35
Frankowska, M., Marcellino, D. J., Adamczyk, P., Filip, M., & Fuxé, K. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00452.x · Cited by 33
Food Addiction and Tobacco Use Disorder: Common Liability and Shared Mechanisms
Zawertailo, L. A., Attwells, S., deRuiter, W. K., Le, T. L., Dawson, D., & Selby, P. L. (2020) · Nutrients · doi:10.3390/nu12123834 · Cited by 37
Dopamine D1 and D2 receptors are distinctly associated with rest-activity rhythms and drug reward
Zhang, R., Manza, P., Tomasi, D. G., Kim, S. W., Kojori, E. S., Demiral, Ş. B., Kroll, D. S., Feldman, D. E., McPherson, K. L., Biesecker, C. L., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149722 · Cited by 35
The Speed of Cocaine Delivery Determines the Subsequent Motivation to Self-Administer the Drug
Minogianis, E.-A., Lévesque, D., & Samaha, A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.173 · Cited by 31
Moeller, S. J., Okita, K., Robertson, C. L., Ballard, M. E., Konova, A. B., Goldstein, R. Z., Mandelkern, M. A., & London, E. D. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.138 · Cited by 28
Narendran, R., Martínez, D., Mason, N. S., Lopresti, B. J., Himes, M. L., Chen, C., May, M. A., Price, J. C., Mathis, C. A., & Frankle, W. G. (2011) · Synapse · doi:10.1002/syn.20970 · Cited by 30
Acquired equivalence and related memory processes in migraine without aura
Őze, A., Nagy, A., Benedek, G., Bodosi, B., Kéri, S., Pálinkás, É., Bihari, K., & Braunitzer, G. (2016) · Cephalalgia · doi:10.1177/0333102416651286 · Cited by 30
Inflammation and infection in human cocaine addiction
Ersche, K. D., & Döffinger, R. (2017) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.12.007 · Cited by 29
Desfossés, J., Stip, É., Bentaleb, L. A., Lipp, O., Chiasson, J., Fürtös, A., Venne, K., Kouassi, É., & Potvin, S. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00085 · Cited by 29
Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review
Tardelli, V. S., do Lago, M. P. P., Mendez, M., Bisaga, A. M., & Fidalgo, T. M. (2018) · Behaviour Research and Therapy · doi:10.1016/j.brat.2018.10.002 · Cited by 30
Attenuated behavioural responses to acute and chronic cocaine in GASP‐1‐deficient mice
Boeuf, J., Trigo, J. M., Moreau, P., Lecourtier, L., Vogel, E., Cassel, J., Mathis, C., Klosen, P., Maldonado, R. J., & Simonin, F. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06865.x · Cited by 29
Yip, S. W., & Potenza, M. N. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.11.003 · Cited by 29
Chen, Y. I., Famous, K. R., Xu, H., Choi, J., Mandeville, J. B., Schmidt, H. D., Pierce, R. C., & Jenkins, B. G. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07806.x · Cited by 29
Chen, R., Ferris, M. J., & Wang, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107583 · Cited by 30
Insights from recent positron emission tomographic studies of drug abuse and dependence
Chang, L., & Haning, W. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000218594.46431.2f · Cited by 27
Hamilton, L. R., Czoty, P. W., Gage, H. D., & Nader, M. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1847-2 · Cited by 28
Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine
Smith, C. T., Dang, L. C., Cowan, R. L., KESSLER, R. M., & Zald, D. H. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.004 · Cited by 25
Temporal Difference Error Prediction Signal Dysregulation in Cocaine Dependence
Rose, E. J., Salmeron, B. J., Ross, T. J., Waltz, J. A., Schweitzer, J. B., McClure, S. M., & Stein, E. A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.21 · Cited by 28
Neural underpinnings of maladaptive decision-making in addictions
Guttman, Z., Moeller, S. J., & London, E. D. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.06.014 · Cited by 28
Positron emission tomography in psychiatric disorders
Newberg, A. B., Moss, A., Monti, D., & Alavi, A. A. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06162.x · Cited by 29
Brain Imaging in Nonhuman Primates: Insights into Drug Addiction
Nader, M. A., & Czoty, P. W. (2008) · ILAR Journal · doi:10.1093/ilar.49.1.89 · Cited by 27
Caravaggio, F., Fervaha, G., Chung, J. K., Gerretsen, P., Nakajima, S., Plitman, E., Iwata, Y., Wilson, A. A., & Graff‐Guerrero, A. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.02.010 · Cited by 26
Use of Stimulants to Treat Cocaine and Methamphetamine Abuse
Moeller, F., Schmitz, J. M., Herin, D., & Kjome, K. L. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0062-x · Cited by 27
Paul, N. M., Taylor, M., Kumar, R., Deschamps, J. R., Luedtke, R. R., & Newman, A. H. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800532x · Cited by 27
Campus, P., Canterini, S., Orsini, C., Fiorenza, M. T., Puglisi‐Allegra, S., & Cabib, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00621 · Cited by 28
Vadhan, N. P., Myers, C. E., Rubin, E., Shohamy, D., Foltin, R. W., & Gluck, M. A. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.09.013 · Cited by 25
Self-citationRutherford, B. R., Slifstein, M., Chen, C., Abi‐Dargham, A., Brown, P. J., Wall, M. W., Vanegas‐Arroyave, N., Stern, Y., Bailey, V. S., Valente, E., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.007 · Cited by 24
Self-citationRetractedSleep-mediated regulation of reward circuits: implications in substance use disorders
Guo, R., Vaughan, D. T., Rojo, A. L. A., & Huang, Y. H. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01356-8 · Cited by 25
Self-citationHulka, L. M., Wagner, M., Preller, K. H., Jenni, D., & Quednow, B. B. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000624 · Cited by 25
García‐García, I., Zeighami, Y., & Dagher, A. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0755-9 · Cited by 28
Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats
Crunelle, C. L., Schulz, S., de Bruin, K. M., Miller, M. L., van den Brink, W., & Booij, J. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.11.001 · Cited by 23
Cannella, N., Ubaldi, M., Masi, A., Bramucci, M., Roberto, M., Bifone, A., & Ciccocioppo, R. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.05.014 · Cited by 24
Psychostimulant Drugs and Neuroplasticity
Fernández‐Espejo, E., & Rodriguez-Espinosa, N. (2011) · Pharmaceuticals · doi:10.3390/ph4070976 · Cited by 25
Molecular imaging in alcohol dependence
Ravan, S., Martínez, D., Slifstein, M., & Abi‐Dargham, A. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-62619-6.00018-5 · Cited by 22
Self-citationSandiego, C. M., Matuskey, D., Lavery, M. E., McGovern, E. M., Huang, Y. H., Nabulsi, N., Ropchan, J. R., Picciotto, M. R., Morris, E. D., McKee, S. A., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.223 · Cited by 21
Self-citationModelling human drug abuse and addiction with dedicated small animal positron emission tomography
Dalley, J. W., Fryer, T. D., Aigbirhio, F. I., Brichard, L., Richards, H. K., Hong, Y. T., Baron, J., Everitt, B. J., & Robbins, T. W. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.029 · Cited by 21
Lee, J., Parish, C. L., Tomas, D., & Horne, M. K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.11.055 · Cited by 19
An autophagy-related protein Becn2 regulates cocaine reward behaviors in the dopaminergic system
Kim, Y.-J., Kong, Q., Yamamoto, S., Kuramoto, K., Huang, M., Wang, N., Hong, J. H., Xiao, T., Levine, B., Qiu, X., et al. (2021) · Science Advances · doi:10.1126/sciadv.abc8310 · Cited by 19
Impaired Learning From Negative Feedback in Stimulant Use Disorder: Dopaminergic Modulation
Lim, T. V., Cardinal, R. N., Bullmore, E. T., Robbins, T. W., & Ersche, K. D. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab041 · Cited by 18
Neurobiology of aversive states
Umberg, E. N., & Pothos, E. N. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.045 · Cited by 22
Garcia, R. C. T., Torres, L. H., Balestrin, N. T., Andrioli, T. C., Flório, J. C., de Oliveira, C. D. R., Costa, J. L., Yonamine, M., Sandoval, M. R. L., Camarini, R., et al. (2016) · Toxicology · doi:10.1016/j.tox.2016.04.009 · Cited by 19
Reducing Addiction in Bipolar Disorder via Hacking the Dopaminergic System
Grunze, H., Csehi, R., Born, C., & Barabássy, Á. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.803208 · Cited by 17
Grunze, H. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2266359 · Cited by 13
Sex and the dopaminergic system: Insights from addiction studies
Woodcock, E. A., Zakiniaeiz, Y., Morris, E. D., & Cosgrove, K. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00011-4 · Cited by 15
Schizophrenia and Substance Abuse Co-Morbidity
O’Daly, O., Guillin, O., Tsapakis, E.-M., Martínez, D., Shergill, S. S., Murray, R. M., & Buckley, P. F. (2005) · Journal of Dual Diagnosis · doi:10.1300/j374v01n02_03 · Cited by 15
Stimulants: Amphetamines and Cocaine
(2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-25733-0_5 · Cited by 14
Smart, K. A., Gallezot, J., Nabulsi, N., Labaree, D. C., Zheng, M., Huang, Y. H., Carson, R. E., Hillmer, A. T., & Worhunsky, P. D. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116762 · Cited by 14
Self-citationTrifilieff, P., & Martínez, D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00005-8 · Cited by 14
Sampedro‐Piquero, P., Santín, L. J., & Castilla‐Ortega, E. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85280 · Cited by 16
Cocaine use as a risk factor for ziprasidone-induced acute dystonia
Duggal, H. S. (2007) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.01.015 · Cited by 13
Hersey, M., Bartole, M. K., Jones, C. S., Newman, A. H., & Tanda, G. (2023) · Molecules · doi:10.3390/molecules28135270 · Cited by 15
Cocaine use disorder is associated with widespread surface-based alterations of the basal ganglia
Xu, H., Xu, C., & Guo, C. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.12.006 · Cited by 12
Brutcher, R. E., & Nader, M. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3672-5 · Cited by 12
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.013 · Cited by 12
A single-day paradigm of self-regulated human cocaine administration
Matuskey, D., Pittman, B. P., Chen, J. I., Wanyiri, J. W., Nadim, H., Jatlow, P. I., Gueorguieva, R. V., Potenza, M. N., MORGAN, P. T., Bhagwagar, Z., et al. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.08.009 · Cited by 12
New treatments for cocaine abuse
Dackis, C. A. (2005) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2005.04.003 · Cited by 11
Lane, S. D., & Green, C. E. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-009 · Cited by 11
Oliver, R. J., Purohit, D. C., Kharidia, K. M., & Mandyam, C. D. (2019) · Brain Sciences · doi:10.3390/brainsci9110330 · Cited by 11
Danielsson, K., Lagström, O., Ericson, M., Söderpalm, B., & Adermark, L. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108638 · Cited by 11
Landa, L., Jurajda, M., & Šulcová, A. (2012) · PubMed · Cited by 11
Caprioli, D., Fryer, T. D., Sawiak, S. J., Aigbirhio, F. I., & Dalley, J. W. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.04.003 · Cited by 10
Vadhan, N. P., Myers, C. E., Benedict, E., Rubin, E., Foltin, R. W., & Gluck, M. A. (2013) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0034506 · Cited by 10
Self-citationInfluence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers
Ciano, P. D., Tyndale, R. F., Mansouri, E., Hendershot, C. S., Wilson, A. A., Lagzdins, D., Houle, S., Boileau, I., & Foll, B. L. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx119 · Cited by 10
Irizar, P., Albein‐Urios, N., Martínez-González, J. M., Verdejo‐García, A., & Lorenzetti, V. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.01.019 · Cited by 10
Brutcher, R. E., & Nader, M. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3101-1 · Cited by 10
Bad Brains: Crime and Drug Abuse from a Neurocriminological Perspective
Jorgensen, C., Anderson, N. E., & Barnes, J. C. (2016) · American Journal of Criminal Justice · doi:10.1007/s12103-015-9328-0 · Cited by 12
The Pathology of Methamphetamine Use in the Human Brain
Kish, S. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00008-3 · Cited by 10
Cumming, P. D., Caprioli, D., & Dalley, J. W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01036.x · Cited by 9
Abbs, B., Achalia, R. M., Adelufosi, A. O., Aktener, A. Y., Beveridge, N. J., Bhakta, S. G., Blackman, R. K., Bora, E., Byun, M. S., Cabanis, M., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.07.024 · Cited by 8
Grzywacz, A., Chmielowiec, J., Chmielowiec, K., Mroczek, B., Masiak, J., Suchanecka, A., Sipak‐Szmigiel, O., Szumilas, K., & Trybek, G. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16152687 · Cited by 9
Narendran, R., Mason, N. S., Himes, M. L., & Frankle, W. G. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.04.001 · Cited by 9
Metadata
- Authors
- Martinez, D., Broft, A., Foltin, R. W., Slifstein, M., Hwang, D.-R., Huang, Y., Perez, A., Frankel, W. G., Cooper, T., Kleber, H. D., Fischman, M. W., & Laruelle, M.
- Affiliations
- Columbia University (US)
- Venue
- Neuropsychopharmacology
- Published
- 2004-03-10
- Volume
- 29
- Issue
- 6
- Pages
- 1190-1202
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2088522292
- Cited by
- 306
- References
- 66
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 10 · 2020: 31 · 2019: 10 · 2018: 8 · 2017: 14 · 2016: 20 · 2015: 7 · 2014: 21 · 2013: 25 · 2012: 31
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Update notices
- erratum (2004-08-23)
- Open access
- closed
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01da010219-06)
- National Institute on Drug Abuse (2-R01-DA10219-01, PA50 DA 09236-06, K08 DA00483-01, P50DA009236, 09236)
- National Center for Research Resources (M01RR000645, M01 RR00645)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- cocaine dependence, dopamine D2 receptor, striatum, [11C]raclopride, limbic striatum, associative striatum, sensorimotor striatum, cocaine self-administration, cocaine-seeking behavior, relapse, addiction vulnerability
- MeSH terms
- Adult, Binding Sites, Brain Mapping, Choice Behavior, Cocaine, Corpus Striatum, Dose-Response Relationship, Drug, Female, Humans, Male, Self Administration, Time Factors, Tomography, Emission-Computed, Case-Control Studies, Receptors, Dopamine D2, Dopamine Antagonists, Dopamine Uptake Inhibitors, Cocaine-Related Disorders, Raclopride
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review